================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) June 14, 2006
LEINER HEALTH PRODUCTS INC.
----------------------------------------------------------
(Exact name of registrant as specified in its charter)
DELAWARE 333-118532 95-3431709
(State or other jurisdiction of (Commission File Number) (IRS Employer
incorporation or organization) Identification Number)
901 East 233rd Street, Carson, California 90745
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (310) 835-8400
--------------
N/A
-------------------------------------------------------------
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[_] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
================================================================================
-1-
================================================================================
Section 2 - Financial Information
Item 2.02 Results of Operations and Financial Condition.
On June 14, 2006, Leiner Health Products Inc. (the "Company") issued a press
release announcing its fiscal fourth quarter and full year results. Attached
hereto as Exhibit 99.1, but only furnished pursuant to Item 2.02 of this report
and incorporated herein by reference, is the Company's press release.
Section 9 - Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits
(c) Exhibits
99.1 Press Release dated June 14, 2006.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
LEINER HEALTH PRODUCTS INC.
By: /s/ Robert Reynolds
--------------------------------
Robert Reynolds
Executive Vice President and
Chief Financial Officer
Date: June 14, 2006
================================================================================
-2-